Dr. Watkins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
115 Porter Dr
Middlebury, VT 05753Phone+1 802-382-3443Fax+1 802-388-5614
Summary
- Dr. Matthew Watkins is a cardiologist in Burlington, VT and is affiliated with multiple hospitals in the area, including University of Vermont Medical Center and Porter Medical Center. He is a Professor of Medicine at the Lerner College of Medicine University of Vermont. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 32 years. He specializes in coronary artery disease and interventional cardiology and is experienced in valvular heart disease, cardiac catheterization, cardiac critical care and ischemic heart failure. His research interests include new therapies in coronary disease and regional quality improvement in interventional cardiology. He is the founding director of the Interventional Cardiology Fellowship program at the University of Vermont Medical Center.
Education & Training
- University of Vermont Medical CenterFellowship, Cardiovascular Disease, 1988 - 1991
- University of Vermont Medical CenterResidency, Internal Medicine, 1985 - 1988
- Perelman School of Medicine at the University of PennsylvaniaClass of 1985
Certifications & Licensure
- VT State Medical License 1991 - 2026
- NY State Medical License 2004 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- AC6 Gene Transfer for CHF Start of enrollment: 2010 Jul 01
- The OMEGA Clinical Trial Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- 14 citationsDesign of a Phase 3 trial of intracoronary administration of human adenovirus 5 encoding human adenylyl cyclase type 6 (RT-100) gene transfer in patients with heart fa...William F. Penny, Timothy D. Henry, Matthew W. Watkins, Amit N. Patel, H. Kirk Hammond
American Heart Journal. 2018-07-01 - 87 citationsIntracoronary Gene Transfer of Adenylyl Cyclase 6 in Patients With Heart Failure: A Randomized Clinical Trial.H. Kirk Hammond, William F. Penny, Jay H. Traverse, Timothy D. Henry, Matthew W. Watkins
JAMA Cardiology. 2016-05-01 - 13 citationsPrimary endpoint results of the OMEGA Study: One-year clinical outcomes after implantation of a novel platinum chromium bare metal stent.John Wang, Didier Carrié, Mónica Masotti, Andrejs Erglis, David Mego
Cardiovascular Revascularization Medicine. 2015-03-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: